Predicting Post-Therapeutic Visual Acuity and OCT Images in Patients With Central Serous Chorioretinopathy by Artificial Intelligence

To predict visual acuity (VA) and post-therapeutic optical coherence tomography (OCT) images 1, 3, and 6 months after laser treatment in patients with central serous chorioretinopathy (CSC) by artificial intelligence (AI). Real-world clinical and imaging data were collected at Zhongshan Ophthalmic C...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fabao Xu, Cheng Wan, Lanqin Zhao, Shaopeng Liu, Jiaming Hong, Yifan Xiang, Qijing You, Lijun Zhou, Zhongwen Li, Songjian Gong, Yi Zhu, Chuan Chen, Li Zhang, Yajun Gong, Longhui Li, Cong Li, Xiayin Zhang, Chong Guo, Kunbei Lai, Chuangxin Huang, Daniel Ting, Haotian Lin, Chenjin Jin
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/77043c3c317c453187143675f523cdb3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:77043c3c317c453187143675f523cdb3
record_format dspace
spelling oai:doaj.org-article:77043c3c317c453187143675f523cdb32021-11-30T13:41:09ZPredicting Post-Therapeutic Visual Acuity and OCT Images in Patients With Central Serous Chorioretinopathy by Artificial Intelligence2296-418510.3389/fbioe.2021.649221https://doaj.org/article/77043c3c317c453187143675f523cdb32021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fbioe.2021.649221/fullhttps://doaj.org/toc/2296-4185To predict visual acuity (VA) and post-therapeutic optical coherence tomography (OCT) images 1, 3, and 6 months after laser treatment in patients with central serous chorioretinopathy (CSC) by artificial intelligence (AI). Real-world clinical and imaging data were collected at Zhongshan Ophthalmic Center (ZOC) and Xiamen Eye Center (XEC). The data obtained from ZOC (416 eyes of 401 patients) were used as the training set; the data obtained from XEC (64 eyes of 60 patients) were used as the test set. Six different machine learning algorithms and a blending algorithm were used to predict VA, and a pix2pixHD method was adopted to predict post-therapeutic OCT images in patients after laser treatment. The data for VA predictions included clinical features obtained from electronic medical records (20 features) and measured features obtained from fundus fluorescein angiography, indocyanine green angiography, and OCT (145 features). The data for OCT predictions included 480 pairs of pre- and post-therapeutic OCT images. The VA and OCT images predicted by AI were compared with the ground truth. In the VA predictions of XEC dataset, the mean absolute errors (MAEs) were 0.074–0.098 logMAR (within four to five letters), and the root mean square errors were 0.096–0.127 logMAR (within five to seven letters) for the 1-, 3-, and 6-month predictions, respectively; in the post-therapeutic OCT predictions, only about 5.15% (5 of 97) of synthetic OCT images could be accurately identified as synthetic images. The MAEs of central macular thickness of synthetic OCT images were 30.15 ± 13.28 μm and 22.46 ± 9.71 μm for the 1- and 3-month predictions, respectively. This is the first study to apply AI to predict VA and post-therapeutic OCT of patients with CSC. This work establishes a reliable method of predicting prognosis 6 months in advance; the application of AI has the potential to help reduce patient anxiety and serve as a reference for ophthalmologists when choosing optimal laser treatments.Fabao XuCheng WanLanqin ZhaoShaopeng LiuJiaming HongYifan XiangQijing YouLijun ZhouZhongwen LiSongjian GongYi ZhuChuan ChenLi ZhangLi ZhangYajun GongLonghui LiCong LiXiayin ZhangChong GuoKunbei LaiChuangxin HuangDaniel TingHaotian LinHaotian LinChenjin JinFrontiers Media S.A.articleartificial intelligencemachine learningcentral serous chorioretinopathyvisual acuityoptical coherence tomographyBiotechnologyTP248.13-248.65ENFrontiers in Bioengineering and Biotechnology, Vol 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic artificial intelligence
machine learning
central serous chorioretinopathy
visual acuity
optical coherence tomography
Biotechnology
TP248.13-248.65
spellingShingle artificial intelligence
machine learning
central serous chorioretinopathy
visual acuity
optical coherence tomography
Biotechnology
TP248.13-248.65
Fabao Xu
Cheng Wan
Lanqin Zhao
Shaopeng Liu
Jiaming Hong
Yifan Xiang
Qijing You
Lijun Zhou
Zhongwen Li
Songjian Gong
Yi Zhu
Chuan Chen
Li Zhang
Li Zhang
Yajun Gong
Longhui Li
Cong Li
Xiayin Zhang
Chong Guo
Kunbei Lai
Chuangxin Huang
Daniel Ting
Haotian Lin
Haotian Lin
Chenjin Jin
Predicting Post-Therapeutic Visual Acuity and OCT Images in Patients With Central Serous Chorioretinopathy by Artificial Intelligence
description To predict visual acuity (VA) and post-therapeutic optical coherence tomography (OCT) images 1, 3, and 6 months after laser treatment in patients with central serous chorioretinopathy (CSC) by artificial intelligence (AI). Real-world clinical and imaging data were collected at Zhongshan Ophthalmic Center (ZOC) and Xiamen Eye Center (XEC). The data obtained from ZOC (416 eyes of 401 patients) were used as the training set; the data obtained from XEC (64 eyes of 60 patients) were used as the test set. Six different machine learning algorithms and a blending algorithm were used to predict VA, and a pix2pixHD method was adopted to predict post-therapeutic OCT images in patients after laser treatment. The data for VA predictions included clinical features obtained from electronic medical records (20 features) and measured features obtained from fundus fluorescein angiography, indocyanine green angiography, and OCT (145 features). The data for OCT predictions included 480 pairs of pre- and post-therapeutic OCT images. The VA and OCT images predicted by AI were compared with the ground truth. In the VA predictions of XEC dataset, the mean absolute errors (MAEs) were 0.074–0.098 logMAR (within four to five letters), and the root mean square errors were 0.096–0.127 logMAR (within five to seven letters) for the 1-, 3-, and 6-month predictions, respectively; in the post-therapeutic OCT predictions, only about 5.15% (5 of 97) of synthetic OCT images could be accurately identified as synthetic images. The MAEs of central macular thickness of synthetic OCT images were 30.15 ± 13.28 μm and 22.46 ± 9.71 μm for the 1- and 3-month predictions, respectively. This is the first study to apply AI to predict VA and post-therapeutic OCT of patients with CSC. This work establishes a reliable method of predicting prognosis 6 months in advance; the application of AI has the potential to help reduce patient anxiety and serve as a reference for ophthalmologists when choosing optimal laser treatments.
format article
author Fabao Xu
Cheng Wan
Lanqin Zhao
Shaopeng Liu
Jiaming Hong
Yifan Xiang
Qijing You
Lijun Zhou
Zhongwen Li
Songjian Gong
Yi Zhu
Chuan Chen
Li Zhang
Li Zhang
Yajun Gong
Longhui Li
Cong Li
Xiayin Zhang
Chong Guo
Kunbei Lai
Chuangxin Huang
Daniel Ting
Haotian Lin
Haotian Lin
Chenjin Jin
author_facet Fabao Xu
Cheng Wan
Lanqin Zhao
Shaopeng Liu
Jiaming Hong
Yifan Xiang
Qijing You
Lijun Zhou
Zhongwen Li
Songjian Gong
Yi Zhu
Chuan Chen
Li Zhang
Li Zhang
Yajun Gong
Longhui Li
Cong Li
Xiayin Zhang
Chong Guo
Kunbei Lai
Chuangxin Huang
Daniel Ting
Haotian Lin
Haotian Lin
Chenjin Jin
author_sort Fabao Xu
title Predicting Post-Therapeutic Visual Acuity and OCT Images in Patients With Central Serous Chorioretinopathy by Artificial Intelligence
title_short Predicting Post-Therapeutic Visual Acuity and OCT Images in Patients With Central Serous Chorioretinopathy by Artificial Intelligence
title_full Predicting Post-Therapeutic Visual Acuity and OCT Images in Patients With Central Serous Chorioretinopathy by Artificial Intelligence
title_fullStr Predicting Post-Therapeutic Visual Acuity and OCT Images in Patients With Central Serous Chorioretinopathy by Artificial Intelligence
title_full_unstemmed Predicting Post-Therapeutic Visual Acuity and OCT Images in Patients With Central Serous Chorioretinopathy by Artificial Intelligence
title_sort predicting post-therapeutic visual acuity and oct images in patients with central serous chorioretinopathy by artificial intelligence
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/77043c3c317c453187143675f523cdb3
work_keys_str_mv AT fabaoxu predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT chengwan predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT lanqinzhao predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT shaopengliu predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT jiaminghong predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT yifanxiang predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT qijingyou predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT lijunzhou predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT zhongwenli predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT songjiangong predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT yizhu predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT chuanchen predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT lizhang predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT lizhang predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT yajungong predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT longhuili predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT congli predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT xiayinzhang predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT chongguo predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT kunbeilai predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT chuangxinhuang predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT danielting predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT haotianlin predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT haotianlin predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
AT chenjinjin predictingposttherapeuticvisualacuityandoctimagesinpatientswithcentralserouschorioretinopathybyartificialintelligence
_version_ 1718406571302584320